AKT1 and hepatocellular carcinoma: Rie et al. reported that HSPB8 can repress hepatocellular carcinoma progression by downregulating the PI3K/AKT signaling, while Yu et al. demonstrated that HSPB8 promoted the migration of lung adenocarcinoma cells by maintaining mitochondrial function [40, 41].